Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.10B | 5.10B | 5.09B | 4.81B | 4.33B | 4.39B |
Gross Profit | 2.48B | 2.53B | 2.46B | 2.30B | 2.16B | 2.19B |
EBITDA | 510.91M | 525.65M | 345.80M | 469.96M | 438.99M | 380.74M |
Net Income | 219.47M | 248.12M | 123.42M | 228.39M | 206.19M | 152.32M |
Balance Sheet | ||||||
Total Assets | 4.34B | 3.40B | 3.43B | 3.31B | 3.25B | 3.32B |
Cash, Cash Equivalents and Short-Term Investments | 11.04M | 5.00M | 22.53M | 165.13M | 185.87M | 307.48M |
Total Debt | 2.33B | 1.36B | 1.35B | 1.19B | 1.21B | 1.32B |
Total Liabilities | 2.92B | 1.99B | 2.08B | 1.87B | 1.84B | 1.95B |
Stockholders Equity | 1.43B | 1.41B | 1.35B | 1.44B | 1.41B | 1.37B |
Cash Flow | ||||||
Free Cash Flow | 383.50M | 280.58M | 220.28M | 191.82M | 133.76M | 356.54M |
Operating Cash Flow | 510.71M | 412.66M | 349.35M | 360.89M | 344.61M | 454.46M |
Investing Cash Flow | -967.55M | -172.67M | -403.81M | -151.09M | -191.44M | -73.99M |
Financing Cash Flow | 461.02M | -257.52M | -88.15M | -222.17M | -274.78M | -84.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $5.00B | 30.48 | 17.35% | 2.07% | 2.00% | 5.39% | |
71 Outperform | $2.89B | 20.10 | 8.22% | ― | 14.22% | -1.81% | |
69 Neutral | $2.37B | 10.67 | 7.88% | 4.28% | 0.87% | 8.59% | |
65 Neutral | $2.21B | 26.92 | 8.79% | 2.75% | 0.50% | -4.46% | |
63 Neutral | $3.13B | 14.77 | 15.61% | 6.52% | -0.61% | 70.09% | |
63 Neutral | $20.46B | 14.51 | -3.60% | 3.15% | 2.60% | -5.31% | |
61 Neutral | $893.35M | 45.21 | 1.34% | ― | -1.52% | ― |
On May 22, 2025, Flowers Foods, Inc. held its Annual Meeting of Shareholders where all 11 director-nominees were elected for one-year terms. The shareholders approved the executive compensation and ratified the appointment of PricewaterhouseCoopers LLP as the independent public accounting firm. However, a shareholder proposal to adopt a policy for an independent board chair was not approved.